683 Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

683 Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,000	Closed	-$49K	–	381
2021 Q4	$49K	Sell	50,000 -200,000	-80%	-$394K	﹤0.01%	319
2021 Q3	$530K	Hold	250,000	–	–	0.02%	157
2021 Q2	$1.15M	Hold	250,000	–	–	0.04%	144
2021 Q1	$1.29M	Hold	250,000	–	–	0.07%	115
2020 Q4	$683K	Buy	+250,000	New	+$628K	0.03%	129

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

683 Capital Management's WGSWW Position: Q1 2022 in Review

683 Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 50,000 shares — an estimated $49K sold.

683 Capital Management first reported a position in WGSWW in Q4 2020 and held it in 5 quarters. The position peaked at $1.29M in Q1 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

683 Capital Management reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
683 Capital Management sold 50,000 GeneDx Holdings Warrant shares in Q1 2022, an estimated $49K.
683 Capital Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 5 quarters.
683 Capital Management's GeneDx Holdings Warrant position peaked at $1.29M in Q1 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on 683 Capital Management's 13F filing for Q1 2022, filed 16 May 2022.